Shivali Lakhani

Shivali Lakhani

Auto-generated profile, based on publicly available information

Shivali Lakhani

School of Public Health, Imperial College, London, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2025 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
MAMarsha Alter
Marsha Alter
SLShivali Lakhani
Shivali Lakhani
AAAos Alaa
Aos Alaa
MKManisha Karki
Manisha Karki
EREva Riboli-Sasco
Eva Riboli-Sasco
Austen El-OstaAusten El-Osta
Austen El-Osta
Background: The United Kingdom’s (UK) integration of Pre-exposure Prophylaxis (PrEP) into community pharmacies presents an alternative avenue for supporting Human Immunodeficiency Virus (HIV) prevention. Despite its effectiveness, PrEP's accessibility remains hindered by various barriers within community settings. The aim of this study was to explore the perspectives of pharmacy team members regarding the barriers and facilitators to the routine provision of PrEP in community pharmacies in the UK, as well as any recommendations for mitigating these challenges. Methods: Exploratory mixed-method cross-sectional study utilising an online survey and semi-structured interviews with community pharmacists and non-pharmacist team members across the North Thames area of London, England. A convenience sample of 110 pharmacy team members participated in the study, including both pharmacists and non-pharmacists. Two pharmacy technicians and eight pharmacists took part in semi-structured interviews. Data collection involved a cross-sectional online survey and semi-structured interviews. The survey collected data such as demographic characteristics, knowledge, and attitudes towards PrEP provision, while interviews explored in-depth perceptions, experiences and recommendations. Results: A significant proportion of respondents expressed a lack of confidence and knowledge regarding PrEP, with training identified as a critical need for facilitating PrEP provision. Additionally, the study highlighted the potential of community pharmacies to increase accessibility of PrEP due to their geographical reach and the trust placed in pharmacists. Conclusion: The study demonstrates an interest from community pharmacies in London in providing a commissioned PrEP supply service. However, this would need to be in conjunction with training programmes and public health campaigns to equip community pharmacies for effective PrEP provision. Enhancing pharmacists' competencies and raising public awareness could significantly support the current HIV prevention strategies in the UK.

1 July 2025 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
AAAos Alaa
Aos Alaa
DMDatapwa Mujong
Datapwa Mujong
SLShivali Lakhani
Shivali Lakhani
MAMarsha Alter
Marsha Alter
Austen El-OstaAusten El-Osta
Austen El-Osta
Background: Despite advancements in HIV prevention, barriers and disparities in accessing Pre-exposure Prophylaxis (PrEP) from specialist services persist. Community pharmacies, with their extensive reach, offer an opportunity to reduce these disparities and help end new HIV infections. Objective: This study aims to investigate the accessibility of HIV PrEP through community pharmacies and sexual health clinics (SHCs) across two London Integrated Care Systems (ICS) in the United Kingdom (UK). We also sought to assess the potential for community pharmacies to enhance access to PrEP and to address existing gaps in PrEP provision in the UK to gauge the potential for community pharmacies to facilitate easier access to PrEP. Methods: We mapped the distribution of pharmacies, PrEP clinics, and SHCs across 11 local authority areas in London, covering North West London ICS and three catchment areas from North Central London ICS using publicly available data, including postcode data. Our selection process for sources of evidence was guided by a set of predefined criteria aimed at identifying community pharmacies and SHCs within the targeted ICSs for their relevance to HIV PrEP accessibility. Two reviewers systematically charted data from each included source. Information extracted included the name of the pharmacy or clinic, address, contact details and operating hours. Results: Our data collection, spanning from April to July 2022, included 692 community pharmacies. The study revealed that 543 (78.5%) of these pharmacies offered sexual health services, with a significant proportion categorised at Tier 2 according to the Umbrella Sexual Health Model, indicating they are well-positioned to offer PrEP services. The mapping showed an uneven distribution of PrEP and sexual health clinics, with community pharmacies widely accessible and offering longer service hours. Conclusion: The findings highlight the critical role community pharmacies could play in providing PrEP, addressing gaps in accessibility, and reducing HIV transmission risks, thus potentially facilitating easier access to PrEP. This study supports the need for policy adjustments to enable community pharmacies to dispense PrEP, aligning with public health goals for broader access to HIV preventative measures.

28 June 2024 in Research Square
Verified
Preprint
Open access
PDF file
MAMarsha Alter
Marsha Alter
SLShivali Lakhani
Shivali Lakhani
AAAos Alaa
Aos Alaa
MKManisha Karki
Manisha Karki
EREva Riboli-Sasco
Eva Riboli-Sasco
Austen El-OstaAusten El-Osta
Austen El-Osta
Background The UK's integration of Pre-exposure Prophylaxis (PrEP) into community pharmacies presents a promising avenue for enhancing HIV prevention. Despite its effectiveness, PrEP's accessibility remains hindered by various barriers within community settings. In this study, we aimed to explore the perspectives of pharmacy team members regarding the barriers and facilitators to the routine provision of HIV PrEP in UK community pharmacies, as well as their recommendations to mitigating these challenges. Methods A mixed-method study utilising an online survey and semi-structured interviews with community pharmacists and non-pharmacist team members across the UK. A convenience sample of 110 pharmacy team members participated in the study, including both pharmacists and non-pharmacist. Two pharmacy technicians and eight pharmacists took part in semi-structured interviews. Data collection involved a cross-sectional online survey and semi-structured interviews. The survey assessed demographic characteristics, knowledge and attitudes towards PrEP provision, while interviews explored in-depth perceptions, experiences and recommendations. Results A significant proportion of respondents expressed a lack of confidence and knowledge regarding PrEP, with training identified as a critical need for facilitating PrEP provision. Additionally, the study highlighted the potential of community pharmacies to increase PrEP accessibility due to their geographical reach and the trust placed in pharmacists. Conclusion The study highlights the necessity for targeted training programs and public health campaigns to equip community pharmacies for effective PrEP provision. Enhancing pharmacists' competencies and public awareness could significantly impact HIV prevention strategies in the UK.

15 March 2022 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
RKRobert S. Kerrison
Robert S. Kerrison
ARAnna Robinson
Anna Robinson
HSHanna Skrobanski
Hanna Skrobanski
GKGhalia Kayal
Ghalia Kayal
AKAradhna Kaushal
Aradhna Kaushal
LMLindsay MacDonald
Lindsay MacDonald

24 June 2026 in Research Square
Verified
Preprint
Open access
PDF file
MAMarhsa
Marhsa
MZMengru Zhang
Mengru Zhang
MAMohammed Adam
Mohammed Adam
SLShivalk Lakhani
Shivalk Lakhani
AUAusten
Austen
Background Community pharmacies in the United Kingdom are increasingly recognised as accessible providers of primary care. Recent policy initiatives, including Pharmacy First, have expanded pharmacists’ roles in managing common conditions traditionally seen in general practice. However, contemporary evidence regarding parental use of pharmacies for child health remains limited. Objective To examine patterns of parental pharmacy use for child health, identify trusted sources of advice and assess demographic and behavioural predictors of pharmacy advice-seeking, trust and willingness to use pharmacy-delivered services. Methods A quota-based cross-sectional online survey of UK parents and caregivers (n = 545) was conducted as part of the Pharmacy PITCH project. Participants completed a 17-item questionnaire examining pharmacy use, advice-seeking behaviour, confidence in pharmacist-delivered advice, trust in pharmacy information and attitudes towards enhanced pharmacy services. Descriptive, bivariate and multivariable regression analyses were performed. Results Over half of respondents (55%) visited pharmacies at least monthly. Prescriptions (72%) and self-care medicines (54%) were the most common reasons for attendance, while 35% sought pharmacist advice. Pharmacies were most consulted for colds (32%), sore throat (34%) and skin rash (29%). Confidence in pharmacist advice was highest for self-limiting respiratory conditions (74–79%) and lowest for injuries (40–51%). Older respondents were more likely to seek pharmacy advice (OR 4.50, 95% CI 1.97–10.28 for age 55–64 vs 18–24), whereas males were less likely (OR 0.47, 95% CI 0.29–0.75). Willingness to vaccinate children at a pharmacy was high (88.5%) and associated with prior pharmacy advice-seeking behaviour. Conclusions UK parents frequently use community pharmacies for common childhood conditions and report substantial confidence in pharmacist-delivered advice. These findings support ongoing expansion of pharmacy-based paediatric minor illness and vaccination services within UK primary care.